We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$232M
AUM Growth
-$37.3M
Cap. Flow
-$107M
Cap. Flow %
-45.9%
Top 10 Hldgs %
59.19%
Holding
75
New
16
Increased
5
Reduced
5
Closed
41

Top Buys

Rank Stock Value
1
GTLS
Chart Industries
GTLS
+$16.1M
2
STZ icon
Constellation Brands
STZ
+$9.57M
3
ALIT icon
Alight
ALIT
+$8.16M
4
LAUR icon
Laureate Education
LAUR
+$7.54M
5
GTLS.PRB
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
+$7.4M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$83.5M
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$31.6M
3
GOSS icon
Gossamer Bio
GOSS
+$8.31M
4
PM icon
Philip Morris
PM
+$5.4M
5
CRBG icon
Corebridge Financial
CRBG
+$4.92M

Sector Composition

Rank Sector Weight
1 Healthcare 19.43%
2 Industrials 8.29%
3 Consumer Staples 6.88%
4 Technology 4.4%
5 Energy 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASLE icon
26
AerSale
ASLE
$279M
$687K 0.3%
+42,344
New +$736K
ACDC icon
27
ProFrac Holding
ACDC
$787M
$630K 0.27%
25,000
-70,000
-74% -$1.55M
AKRO
28
DELISTED
Akero Therapeutics
AKRO
– –
-65,000
Closed -$2.21M
ALHC icon
29
Alignment Healthcare
ALHC
$2.98B
– –
-160,000
Closed -$1.89M
ALNY icon
30
Alnylam Pharmaceuticals
ALNY
$29.3B
– –
-3,000
Closed -$600K
ARGX icon
31
argenx
ARGX
$54.1B
– –
-12,000
Closed -$4.24M
CCL icon
32
Carnival Corporation Ltd
CCL
$39.7B
– –
-364,666
Closed -$2.56M
CDTX
33
DELISTED
Cidara Therapeutics
CDTX
– –
-18,455
Closed -$232K
CNM icon
34
Core & Main
CNM
$8.71B
– –
-110,000
Closed -$2.5M
CRBG icon
35
Corebridge Financial
CRBG
$15B
– –
-250,000
Closed -$4.92M
DCGO icon
36
DocGo
DCGO
$62.6M
– –
-175,000
Closed -$1.74M
EYPT icon
37
EyePoint Inc
EYPT
$1.2B
– –
-220,000
Closed -$1.74M
FULC icon
38
Fulcrum Therapeutics
FULC
$297M
– –
-200,000
Closed -$1.62M
GOSS icon
39
Gossamer Bio
GOSS
$87M
– –
-693,477
Closed -$8.31M
IDYA icon
40
IDEAYA Biosciences
IDYA
$3.56B
– –
-60,000
Closed -$895K
LXU icon
41
LSB Industries
LXU
$693M
– –
-31,500
Closed -$449K
MIRM icon
42
Mirum Pharmaceuticals
MIRM
$6.14B
– –
-30,000
Closed -$630K
MLTX icon
43
MoonLake Immunotherapeutics
MLTX
$1.55B
– –
-191,945
Closed -$1.49M
PAX icon
44
Patria Investments
PAX
$1.86B
– –
-30,000
Closed -$392K
PM icon
45
Philip Morris
PM
$295B
– –
-65,000
Closed -$5.4M
RLAY icon
46
Relay Therapeutics
RLAY
$4.33B
– –
-30,400
Closed -$680K
SLVM icon
47
Sylvamo
SLVM
$1.63B
– –
-90,000
Closed -$3.05M
SMRT icon
48
SmartRent
SMRT
$272M
– –
-200,000
Closed -$454K
SOFI icon
49
SoFi Technologies
SOFI
$23.7B
– –
-320,000
Closed -$1.56M
SRZNW icon
50
Surrozen Inc Warrant
SRZNW
$8.86K
– –
-127,280
Closed -$23K
1
2
3

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Monashee Investment Management held 75 positions worth $232M, down 14% from $270M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Monashee Investment Management withdrew a net $107M in Q4 2022, closing 41 positions and reducing 5 holdings. Its most notable exit was Gossamer Bio, an estimated $8.31M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Monashee Investment Management opened a new position in Chart Industries worth $11.5M.

  • Monashee Investment Management's largest Q4 2022 buy was Chart Industries: 100,000 shares worth $11.5M.
  • Monashee Investment Management added most to Compass Therapeutics in Q4 2022, an estimated $3.99M increase.
  • Monashee Investment Management's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $83.5M.
  • Monashee Investment Management fully exited Gossamer Bio in Q4 2022, selling an estimated $8.31M.
  • Monashee Investment Management's ten largest holdings make up 59% of its $232M portfolio in Q4 2022.
  • Monashee Investment Management opened 16 new positions and closed 41 in Q4 2022.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $232M.

Based on Monashee Investment Management's 13F filing for Q4 2022, filed 9 Feb 2023.